CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $247,777
- in 3 filings, $248K under 10b5-1 plans
Net −$207,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-20 | Rhodes Jason P Director | Sale 10b5-1 | −166,029 | $22.71 | $3.8M | 6,819,475 |
| 2024-02-20 | Rhodes Jason P Director | Sale 10b5-1 | −3,510 | $23.40 | $82K | 6,815,965 |
| 2024-02-20 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −166,029 | $22.71 | $3.8M | 6,819,475 |
| 2024-02-20 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −3,510 | $23.40 | $82K | 6,815,965 |
| 2024-02-16 | Rhodes Jason P Director | Sale 10b5-1 | −162,707 | $23.14 | $3.8M | 6,985,504 |
| 2024-02-16 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −162,707 | $23.14 | $3.8M | 6,985,504 |
| 2024-02-15 | Rhodes Jason P Director | Sale 10b5-1 | −175,793 | $23.88 | $4.2M | 7,150,324 |
| 2024-02-15 | Rhodes Jason P Director | Sale 10b5-1 | −2,113 | $24.45 | $52K | 7,148,211 |
| 2024-02-15 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −175,793 | $23.88 | $4.2M | 7,150,324 |
| 2024-02-15 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −2,113 | $24.45 | $52K | 7,148,211 |
| 2024-02-12 | Farwell Wildon Chief Medical Officer | Sale 10b5-1 | −5,493 | $25.07 | $138K | 163,503 |
| 2024-01-29 | Brumm Joshua T CEO & President | Gift | −20,000 | 564,971 | ||
| 2024-01-29 | Brumm Joshua T CEO & President | Gift | −1,500 | 563,471 | ||
| 2024-01-26 | Farwell Wildon Chief Medical Officer | Sale 10b5-1 | −100 | $25.00 | $3K | 168,996 |
| 2024-01-26 | McNeill Jonathan Chief Business Officer | Option exercise 10b5-1 | +20,000 | $0.73 | $15K | 163,618 |
| 2024-01-26 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −19,822 | $24.52 | $486K | 143,796 |
| 2024-01-26 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −178 | $25.14 | $4K | 143,618 |
| 2024-01-26 | McNeill Jonathan Chief Business Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 28,528 | ||
| 2024-01-26 | Scalzo Richard William SVP, Head of Finance & Admin. | Option exercise 10b5-1 | +13,000 | $1.03 | $13K | 137,228 |
| 2024-01-26 | Scalzo Richard William SVP, Head of Finance & Admin. | Sale 10b5-1 | −13,000 | $24.34 | $316K | 124,228 |
Page 26 of 29 · 561 trades